About Us

Ayrton Capital is an absolute-return focused investment firm that combines fundamental research, quantitative analysis and portfolio structuring to identify and allocate capital to attractive investment opportunities. We are asset-class, geography and sector agnostic, seeking to invest in passionate management teams that are singularly focused on creating value for their stakeholders.

Our mission is to generate exceptional investment returns through a culture of excellence that emphasizes curiosity, concentration, perseverance and self-improvement.


If you don't have access, click on the button to request access to all sections


At Ayrton, we analyze each investment with a singular goal - to identify possible outcomes and their probabilities. In doing so we answer several key questions - what is a company’s track record of success? What secular or structural dynamics are driving or destroying value in the sector? Has management delivered on previously guided goals? Does the situation lie within our domain of competence? In answering these questions objectively and truthfully, we are able to act on undervalued or unappreciated opportunities.


Discipline and rigor of process are vital for investment success. Ours starts with a comprehensive review of data gathered through screening or through interactions with trusted market contacts. Observations derived from this review are further refined with retrospective and preemptive thinking thereby reducing an investment thesis to its salient elements. Long term insights gained from this work makes our technique iteratively smarter. Underlying all this is a fundamental tenet of successful investing - the only sustainable way to win is through rigorous preparation, discipline, patience and decisiveness.


  • Emphasize capital preservation and margin of safety.
  • Adhere to absolute standards of value.
  • Insist upon proper compensation for risk (even if others don't).
  • No investment is sacred when a better one comes along.
  • Reputation and integrity are one’s most valuable assets; never compromise.
  • Good ideas are rare - when the odds are greatly in one's favor, allocate heavily.
  • Reject flawed concepts such as:
    • Being compelled to stay fully invested at all times.
    • Comparative ranking that forces short term, chase-the-herd behavior.
    • Over categorization.
  • Resist the human bias to act; accept that sometimes doing nothing is best.
  • Be aware and adapt to reality; it won't adapt to you.


If you don't have access, click on the button to request access to all sections

All Weather Performance

Successful investing occurs at the confluence of sound data gathering, insightful research, tactical execution and round-the-clock oversight. Importantly, this convergence must occur within and across silos - in fact attractive investments often lie outside traditional categories overlooked by institutional investors.

We consciously eschew pigeonholing ourselves along such categories, instead focusing on applying our well-defined set of analytical skills to asset classes worldwide. Armed with a flexible investment mandate and a collaborative approach, we are able to allocate capital opportunistically with a goal to generate best-in-class investment returns. We invest in the healthcare, technology, natural resources and consumer sectors and express our views across the capital structure via debt, equity and equity-linked securities.

Risk Management

Risk assessment is interwoven directly into our portfolio construction process as early as pre-trade discussions. This philosophy ensures that risk estimation is front and center while an investment's price, size and portfolio contribution is being evaluated. This mindset is further extended in ex-post reviews, where positions are continuously monitored for market risk, operational complexity, sensitivity to financing and capital intensity. Finally, impact of tail-events and cross-asset liquidation risks are mitigated at the portfolio level to ensure capital preservation in difficult markets.


If you don't have access, click on the button to request access to all sections

Waqas Khatri

Founder and Chief Investment Officer

Ayrton was founded by Waqas Khatri in December 2016 after a successful investment career at Oasis Capital Management and Tenor Capital Management where he ran portfolios active in private placements, convertible arbitrage, volatility arbitrage, event-driven/distressed and risk arbitrage. Prior to that, Mr. Khatri was a Vice President at JPMorgan Asset Management responsible for selection of investment managers deploying relative value strategies. Mr. Khatri graduated from Vassar College, New York in 2002 with a BA in Computer Science and Economics. He is a founding board member of the Karen Leung Foundation, a charitable organization with a mission is to save lives by reducing the impact of gynaecological cancers in Hong Kong.

Marian Freidin

Operations Manager

Marian Freidin joined Ayrton in August 2017 and serves as its Operations Manager, responsible for the firm’s fund accounting, tax, treasury and trade operations. Prior to joining Ayrton, Ms. Freidin was a client service analyst with the Prime Brokerage division at Maxim Group LLC where she supported client integration with Maxim’s trade, finance and compliance infrastructure. Ms. Freidin holds degrees in Business Management and Equine Science from Colorado State.

Eric Arinsburg

Managing Director

Eric Arinsburg joined Ayrton in January 2021 as a Portfolio Manager responsible for convertible arbitrage. Mr. Arinsburg was previously a Managing Director at CNH Partners (the arbitrage affiliate of AQR Capital) responsible for over $5 billion of assets. Additionally, he is a co-founder of CNH Finance, an asset-backed lender focusing on healthcare loans, and Source Identity, a software company specializing in data collection in the aerospace and defense supply chain. Mr. Arinsburg has a BS in Applied Economics and Management from Cornell University and an MBA from the Wharton School of the University of Pennsylvania.

Samar Hamza

Research Analyst

Samar Hamza joined Ayrton in August 2018 and acts as the firm’s research analyst, covering the biotechnology, specialty pharmaceutical and medical device sectors. Ms. Hamza was previously a clinical researcher at UC San Diego assisting with clinical study design, implementation and data analysis. Some of her research work included neurodegeneration and neuro-imaging. Ms. Hamza was also a research consultant with Mark Kreuger & Associates, a leading patient engagement and advocacy consulting firm to the biopharmaceutical industry. She holds a Masters in Public Health with a concentration in Epidemiology and Statistics from Columbia University and a BS in Biology from University of California, San Diego.

Jarryd Gross

Research Analyst

Jarryd Gross joined Ayrton in April 2021 and acts as a research analyst for the firm. Prior to joining Ayrton, Mr. Gross served as an Equity Capital Markets Associate at H.C. Wainwright & Co., where he focused on the structuring and execution of numerous capital raises for small and micro cap companies across multiple sectors. Mr. Gross has also held ECM positions with Robert W. Baird and Baader Helvea AG. He holds dual bachelor degrees in Commerce and Economics, with majors in Finance, Accounting and Economics from the University of New South Wales, Sydney Australia


Ayrton’s success as an investment manager is a direct corollary of its team. Individuals join us not just for their contribution to investment success but also for diversity of intellectual capital. We are deeply committed to attracting and nurturing talent that enhances our understanding of the world and enriches the firm’s culture.

Candidates are welcome to contact us at careers@ayrtonllc.com.

Contact Us

55 Post Rd W, 2nd Floor, Westport, Connecticut 06880, US

Copyright © Ayrton Capital LLC – All rights reserved.

Terms of Use:

The information contained on this website (the “Website”) is proprietary information belonging to Ayrton Capital LLC (the “Adviser”). This information may not be reproduced, in whole or in part, without the written express consent of the Adviser. The information at this Website is protected under the applicable copyright laws in the United States and other countries. Unauthorized retransmission, redistribution or other reproduction or modification of information contained in this Website is prohibited and may be a violation of laws, including trademark or copyright laws and could subject the user to legal action.

The Adviser does not guarantee the accuracy of this Website and the information contained therein, and such information may be incomplete or condensed. The Website may be updated at any time without notice to you, and any changes will be binding upon you if you continue to use the Website. By entering this Website, you acknowledge that all of the information contained herein shall be in strict confidence by you.

The Website is for informational purposes only and is not intended as an offer or solicitation with respect to the purchase or sale of any security or of any fund or account the Adviser manages or offers. Such offers will be made only by distribution of a private placement memorandum, subscription agreement, limited partnership agreement, articles of association or other offering documents as applicable (collectively the “Offering Documents”), and only in compliance with applicable law. The Adviser and its respective affiliates, officers, directors, employees, principals or agents, shall not be liable for damages arising out of any errors or omissions in the production or content of the Website nor will they under any circumstances be liable to you or any other person for any loss or damage (whether direct, indirect, special, incidental, economic, or consequential, exemplary or punitive) arising from, connected with, or relating to the use of, or inability to use, the Website, or any action or decision made by you or any other person in reliance on the Website (which you agree not to take on the basis of any of the information set forth herein), any material misstatements or omissions in the information presented, or any unauthorized use of reproduction of the Website.

The Website and the information contained therein should not be the basis of an investment decision. An investment decision should be based on your customary and thorough due diligence procedures, which should include, but not be limited to, a thorough review of all relevant term sheets and other offering documents as well as consolation with legal, tax and regulatory experts. Any person subscribing for an investment must be able to bear the risks involved and must meet the particular fund or account’s suitability requirements. No assurance can be given that any fund or account will meet its investment objectives or avoid losses. The terms set forth in the Offering Documents are controlling in all respects should they conflict with any other term set forth in this Website or any other marketing materials, and therefore, the Offering Documents must be reviewed carefully before making an investment and periodically while an investment is maintained.